Sagent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has fifty-six approved drugs.
Drugs and US Patents for Sagent Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | OCTREOTIDE ACETATE | octreotide acetate | INJECTABLE;INJECTION | 091041-001 | Nov 12, 2013 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 091676-002 | Jul 13, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 207426-001 | Dec 8, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | EPHEDRINE SULFATE | ephedrine sulfate | SOLUTION;INTRAVENOUS | 214528-001 | Mar 9, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 207264-001 | Jul 11, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.